Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anders Tengblad is active.

Publication


Featured researches published by Anders Tengblad.


Scandinavian Journal of Primary Health Care | 2007

Self-monitoring of blood glucose and glycaemic control in type 2 diabetes

Anders Tengblad; Ewa Grodzinsky; Kjell Lindström; Sigvard Mölstad; Lars Borgquist; Carl Johan Östgren

Objective. Previous studies have shown inconsistent results with regard to whether or not self-monitoring of blood glucose (SMBG) is related to better glycaemic control in type 2 diabetes. The aim of this study was to explore the use of SMBG and its association with glycaemic control in patients with type 2 diabetes in primary care. Design. A cross-sectional observational study was conducted in 2003 at 18 primary health care centres in Sweden, in which all known patients with diabetes were surveyed. The study included 6495 patients with type 2 diabetes. A sample of 896 patients was selected for further exploration of data from medical records. A telephone interview was performed with all patients in this group using SMBG (533 patients). Results. There were no differences in HbA1c levels between users (6.9%) and non-users (6.8%) of SMBG in patients treated with insulin or in patients treated with oral agents (6.3% in both groups). In patients treated with diet only, users of SMBG had higher levels of HbA1c compared with non-users (5.5% vs. 5.4%, p =0.002). Comparing medical records between users and non-users of SMBG showed no differences in diabetes-related complications in any treatment category group. Conclusion. The use of SMBG was not associated with improved glycaemic control in any therapy category of patients with type 2 diabetes in primary care. The absence of difference in glycaemic control between users and non-users of SMBG could not be explained by differences in comorbidity between users and non-users of SMBG.


European Journal of Endocrinology | 2014

Vitamin D deficiency in elderly people in Swedish nursing homes is associated with increased mortality

Maria Samefors; Carl Johan Östgren; Sigvard Mölstad; Christina Lannering; Patrik Midlöv; Anders Tengblad

OBJECTIVE Institutionalised elderly people at northern latitudes may be at elevated risk for vitamin D deficiency. In addition to osteoporosis-related disorders, vitamin D deficiency may influence several medical conditions conferring an increased mortality risk. The aim of this study was to explore the prevalence of vitamin D deficiency and its association with mortality. DESIGN The Study of Health and Drugs in the Elderly (SHADES) is a prospective cohort study among elderly people (>65 years) in 11 nursing homes in Sweden. METHODS We analysed the levels of 25-hydroxyvitamin D₃ (25(OH)D₃) at baseline. Vital status of the subjects was ascertained and hazard ratios (HRs) for mortality according to 25(OH)D₃ quartiles were calculated. RESULTS We examined 333 study participants with a mean follow-up of 3 years. A total of 147 (44%) patients died within this period. Compared with the subjects in Q4 (25(OH)D₃ >48  nmol/l), HR (with 95% CI) for mortality was 2.02 (1.31-3.12) in Q1 (25(OH)D₃ <29  nmol/l) (P<0.05); 2.03 (1.32-3.14) in Q2 (25(OH)D₃ 30-37  nmol/l) (P<0.05) and 1.6 (1.03-2.48) in Q3 (25(OH)D₃ 38-47  nmol/l) (P<0.05). The mean 25(OH)D₃ concentration was 40.2  nmol/l (S.D. 16.0) and 80% had 25(OH)D₃ below 50  nmol/l. The vitamin D levels decreased from baseline to the second and third measurements. CONCLUSIONS Vitamin D deficiency was highly prevalent and associated with increased mortality among the elderly in Swedish nursing homes. Strategies are needed to prevent, and maybe treat, vitamin D deficiency in the elderly in nursing homes and the benefit of vitamin D supplementation should be evaluated in randomised clinical trials.


Diabetes & Metabolism | 2014

Abdominal obesity and low-grade systemic inflammation as markers of subclinical organ damage in type 2 diabetes

Elsa M Dahlén; Anders Tengblad; Toste Länne; B. Clinchy; Jan Ernerudh; Fredrik Nyström; Carl Johan Östgren

AIM This study aimed to explore the associations between abdominal obesity, inflammatory markers and subclinical organ damage in 740 middle-aged patients with type 2 diabetes. METHODS Waist circumference (WC) and sagittal abdominal diameter (SAD) were measured, and blood samples were analyzed for C-reactive protein (CRP) and IL-6. Carotid intima-media thickness (IMT) was evaluated by ultrasonography, and aortic pulse wave velocity (PWV) measured with applanation tonometry. RESULTS Abdominal obesity as determined by SAD and WC was significantly correlated with IL-6 (WC: r=0.27, P<0.001; SAD: r=031, P<0.001), CRP (WC: r=0.29, P<0.001; SAD: r=0.29, P<0.001), IMT (WC: r=0.09, P=0.013; SAD: r=0.11, P=0.003) and PWV (WC: r=0.18, P<0.001; SAD: r=0.21, P<0.001). In multiple linear regressions with IMT and PWV as dependent variables, and age, gender, statin use, systolic blood pressure (SBP), body mass index (BMI), CRP and HbA1c as independent variables, both SAD and WC remained associated with IMT and PWV. On stepwise linear regression and entering both SAD and WC, the association between SAD and PWV was stronger than the association between WC and PWV. CONCLUSION Both SAD and WC are feasible measures of obesity, and both provide information on inflammation, atherosclerosis and arterial stiffness in type 2 diabetes, while SAD appears to be slightly more robustly associated with subclinical organ damage than WC.


Nutrition Metabolism and Cardiovascular Diseases | 2017

The impact of using sagittal abdominal diameter to predict major cardiovascular events in European patients with type 2 diabetes

Karin Rådholm; Anders Tengblad; Elsa M Dahlén; Toste Länne; Jan Engvall; Fredrik Nyström; Carl Johan Östgren


Archive | 2009

Monitoring blood glucose and obesity in type 2 diabetes in primary care

Anders Tengblad


Archive | 2005

Frequency of self monitoring of blood glucose in type 2 diabetes and glycaemic control in a Swedish primary care setting.

Anders Tengblad; Ewa Grodzinsky; Kjell Lindström; Sigvard Mölstad; Carl Johan Östgren


BMC Nutrition | 2016

Low carbohydrate diet and obesity treatment in primary health care: dietary advice after the new Swedish report

Gabriella Barabas; Anders Tengblad; Carl Johan Östgren


Journal of Clinical Metabolism & Diabetes | 2011

Sagittal abdominal diameter and waist circumference as markers of early organ damage in patients with Type 2 diabetes

Anders Tengblad; Toste Länne; Jan Engvall; Fredrik Nyström; Carl Johan Östgren


Archive | 2009

Health care costs and glycaemic control in type 2 diabetesin Swedish primary care

Anders Tengblad; Lars Borgquist; Sigvard Mölstad; Carl Johan Östgren


Läkartidningen | 2009

Fördel minska diabetesbehandling hos svårt multisjuka med lågt HbA1c : Positiva resultat från utsättningsstudie bland äldre i särskilt boende

Carl Johan Östgren; Peter Sjöblom; Anders Tengblad; Ulla-Britt Löfgren; Ulf Rosenqvist; Sigvard Mölstad

Collaboration


Dive into the Anders Tengblad's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge